Abstract:OBJECTIVE:The application of dexmedetomidine in patient sedation is generally accepted, though its clinical application is limited because of the lack of information detailing the specific properties among diverse populations of patients. The aim of this study was to compare the pharmacokinetic and pharmacodynamic characteristics of dexmedetomidine between elderly and young patients during spinal anesthesia.METHODS:34 subjects (elderly group: n = 15; young group: n = 19) with spinal anesthesia were enrolled in the present study following the inclusion/exclusion criteria detailed below. All subjects received intravenous infusion of dexmedetomidine with a loading dose of 0.5 µg x kg⁻¹ for 10 minutes and a maintenance dose of 0.5 µg x kg⁻¹ x h⁻¹ for 50 minutes. Plasma concentrations of dexmedetomidine were detected by the HPLC-MS/MS method and pharmacokinetic parameters were calculated using WinNolin software.RESULTS:There was no significant difference between the elderly and young subjects in major pharmacokinetic parameters. There was a marked gender difference in the Cmax (peak plasma concentration) and tmax (time to reach Cmax) between genders in elderly subjects, though in this cohort the other pharmacokinetic parameters were not significantly different. In the young subjects there were no noteworthy variations between genders in pharmacokinetic parameters. There was no significant difference between the two groups in BISAUC(0-t) (the area under the bispectral index-time curve from time 0 to t hours), BISmin (the minimum value of the bispectral index after drug delivery), and or tmin-BIS (bispectral index for the minimum value of time). SBP (systolic blood pressure), DBP (diastolic blood pressure), HR (heart rate), and SpO₂(pulse oxygen saturation) developed substantive differences in a time-dependent manner, but there were no statistically significant differences in these four indicators in the time*group at three time points (1 hour, 2 hours, and 3 hours after drug administration); while SBP was significantly different between the groups, this differential declined in a time-dependent manner, and there were no significant attendant differences in the D-value. The observed values and D-values of DBP and HR were similar in the groups, but the observed value and D-value of SpO₂did differ. There were 14 drug-related adverse events in the young group, and 26 drug-related adverse events in the elderly group, a 46% differential. The percentage of patients who requiring intervention during surgery was 68.75% (11/16) in the elderly group and 36.84% (7/19) in the young group, with no significant difference between the two groups once age was factored in (p = 0.06). None of the pharmacodynamic indices, however, correlated with the key pharmacokinetic parameters (Cmax, AUC(0→t), AUC(0→∞)) of dexmedetomidine.CONCLUSIONS:The clearance of dexmedetomidine in elderly patients showed a declining trend compared to young patients. Interventions in the elderly group were more frequent than in the young group, and the elderly group showed significant adverse effects. It is suggested that elderly patients who use dexmedetomidine may benefit from a different dose. However, further research with a larger population size is required to confirm these findings.

Dexmedetomidine for Sedation During Low Epidural Anesthesia in 22 Elderly Patients

Clinical trial of dexmedetomidine in anesthesia of elderly patients with hip fracture

Pharmacokinetic and Pharmacodynamic Study of Dexmedetomidine in Elderly Patients During Spinal Anesthesia

Effect of dexmedetomidine on convalescence quality after general anesthesia and postoperative delirium, and on cognitive function in elderly patients undergoing lower limb surgery

The effect of dexmedetomidine on the incidence of postoperative delirium in critically ill elderly patients

Sedative effect of different speed of intravenous infusion of dexmedetomidine detected by Narocotrend index on elderly patients

The Sedative Effect of Dexmedetomidine on the Patient Undergoing Epidural Anesthesia

Effects of dexmedetomidine combined with propofol on painless gastroscopy and colonoscopy in the elderly

[Sedative Effects of Dexmedetomidine in Post-Operative Elder Patients on Mechanical Ventilation].

Application of dexmedetomidine in the aged patients with total hip replacement surgery

Clinical Observation of Dexmedetomidine Sedation in Patients Undergoing Percutaneous Nephrolithotomy with Spinal Anesthesia

Clinical Effect of Dexmedetomidine Combined with Dezocine in Elderly Patients with Upper Abdominal Operation During Recovery from General Anesthesia

Intraoperative use of low-dose dexmedetomidine for the prevention of emergence agitation following general anaesthesia in elderly patients: a randomized controlled trial

Determination of the Median Effective Dose of Dexmedetomidine for the Prevention of Emergence Agitation in Geriatric Patients Undergoing Major Open Surgery With General Anesthesia: A Prospective, Double-Blinded, Dose-Response Trial

Effect of low-dose dexmedetomidine to prolong spinal anesthesia in elderly patients: a prospective randomized controlled study

Effects of Dexmedetomidine During Combined Intravenous-Inhalational Anesthesia on Motor Evoked Potentials Monitoring and Postoperative Agitation in Elderly Patients Undergoing Cervical Spine Sur-Gery

A feasibility study of dexmedetomidine nasal drops for endoscopic sinus surgery in geratic patients

Quantitative Evaluation of the Conscious-Sedation Effects of a Single Loading Dose of Dexmedetomidine

Dexmedetomidine Sedation Effect of Combined Spinal-epidural Anesthesia for Patients Undergoing Operation under Analysis

Anesthetic Effect of Dexmedetomidine in Pelvic Floor Reconstructive Surgery of Elderly Patients with Pelvic organ Prolapse

Effect of Dexmedetomidine on postoperative analgesia of Sufentanil in elderly patients after lumbar spine surgery